Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3289-6
Published Online: 2017-03-24
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jang, JoungSoon
Kim, Hoon-Kyo
Cho, Byoung Chul
Lee, Kyung Hee
Yun, Hwan-Jung
Woo, In Sook
Song, Hong Suk
Ryoo, Hun-Mo
Kim, Chi-Hong
Sun, Der-Sheng
Shin, Jong Wook
License valid from 2017-03-24